Results 1 to 10 of about 1,467 (85)

Brainstem Neuroadaptations in Rodent Models of Parkinson's Disease. [PDF]

Eur J Neurosci
Al Tannir R, Pautrat A, Soutrenon R, Overton PG, Coizet V.   +4 more
europepmc   +1 more source

Neurogrit Gold Attenuates 6-OHDA-Induced Dopaminergic Neurodegeneration in Parkinson's Model of Caenorhabditis elegans by Reducing α-Synuclein Accumulation and Pink/Pdr-1 Driven Mitochondrial Dysfunction. [PDF]

CNS Neurosci Ther
Balkrishna A, Pathak N, Singh R, Gohel V, Varshney Y, Dev R, Varshney A.   +6 more
europepmc   +1 more source

MRI-guided focused ultrasound for treating Parkinson's disease with human mesenchymal stem cells. [PDF]

Sci Rep
Wu SK, Tsai CL, Mir A, Hynynen K.
europepmc   +1 more source

Zooming into Gut Dysbiosis in Parkinson's Disease: New Insights from Functional Mapping. [PDF]

Int J Mol Sci, 2023
Turco L, Opallo N, Buommino E, De Caro C, Pirozzi C, Mattace Raso G, Lembo F, Coretti L.   +7 more
europepmc   +1 more source

Olfactory Dysfunction in a Novel Model of Prodromal Parkinson's Disease in Adult Zebrafish. [PDF]

Int J Mol Sci
Vorhees NW, Groenwold SL, Williams MT, Putt LS, Sanchez-Gama N, Stalions GA, Taylor GM, Van Dort HE, Calvo-Ochoa E.   +8 more
europepmc   +1 more source

A_2A Adenosine Receptor Antagonists and Their Efficacy in Rat Models of Parkinson's Disease. [PDF]

Cells
Spinaci A, Buccioni M, Dal Ben D, Francucci B, Klotz KN, Marucci G, Simola N, Morelli M, Pinna A, Volpini R, Lambertucci C.   +10 more
europepmc   +1 more source

Biofilm proficient Bacillus subtilis prevents neurodegeneration in Caenorhabditis elegans Parkinson's disease models via PMK-1/p38 MAPK and SKN-1/Nrf2 signaling. [PDF]

Sci Rep
Francisco M, Grau R.
europepmc   +1 more source

Striatal Serotonin 4 Receptor is Increased in Experimental Parkinsonism and Dyskinesia. [PDF]

J Parkinsons Dis
Cirillo R, Duperrier S, Parekh P, Millot M, Li Q, Thiolat ML, Morelli M, Xie J, Le Bars D, Redouté J, Bezard E, Sgambato V.   +11 more
europepmc   +1 more source

Gray level co-occurrence matrix algorithm as pattern recognition biosensor for oxidopamine-induced changes in lymphocyte chromatin architecture

Journal of Theoretical Biology, 2016
We demonstrate that a proapoptotic chemical agent, oxidopamine, induces dose dependent changes in chromatin textural patterns which can be quantified using the Gray level co-occurrence matrix (GLCM) method. Peripheral blood (heparin-pretreated) samples were treated with oxidopamine (6-OHDA, 6-hydroxydopamine) to achieve effective concentrations of 100,
Si-yang Zheng, Dejan Nesic, Igor Pantic
exaly   +6 more sources

Role of the sympathetic nervous system in cancer-associated cachexia and tumor progression in tumor-bearing BALB/c mice. [PDF]

BMC Neurosci
Gutierrez-Leal I, Caballero-Hernández D, Orozco-Flores AA, Gomez-Flores R, Quistián-Martínez D, Tamez-Guerra P, Tamez-Guerra R, Rodríguez-Padilla C.   +7 more
europepmc   +1 more source